By demonstrating that circATP9A fosters the progression of NSCLC through its interaction with the HuR protein and the subsequent amplification of NUCKS1 mRNA and protein levels, we have uncovered a novel regulatory mechanism in lung cancer pathology. This evidence concerns the gene ELAVL1 and lung carcinoma.